Côd QR

Loss of CYLD promotes splenic marginal zone lymphoma

Abstract Splenic marginal zone lymphoma (SMZL) is a distinct clinical and pathological entity among marginal zone lymphomas. Genetic and microenvironmental factors leading to aberrant activation of the NF‐κB pathway have been implicated in SMZL pathogenesis. CYLD is a negative regulator of NF‐κB and...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Athanasios Pseftogas, Jessica Bordini, Silvia Heltai, Ferdinando Bonfiglio, Georgios Gavriilidis, Vasileios Vasileiou, Sofoklis Keisaris, Daniela Belloni, Caterina Taccetti, Pamela Ranghetti, Eleonora Perotta, Michela Frenquelli, Uday Aditya Sarkar, Elisa Albi, Francesca Martini, Emmanuela Sant'Antonio, Fabrizio Mavilia, Fotis Psomopoulos, Manasori Daibata, José Ángel Martínez Climent, George Mosialos, Davide Rossi, Alessandro Campanella, Lydia Scarfò, Kostas Stamatopoulos, Konstantinos Xanthopoulos, Paolo Ghia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wiley 2025-03-01
Cyfres:HemaSphere
Mynediad Ar-lein:https://doi.org/10.1002/hem3.70098
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg